NasdaqGS - Nasdaq Real Time Price • USD
Elevation Oncology, Inc. (ELEV)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 957.45k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FERRA JOSEPH J. JR. Chief Executive Officer | -- | Direct | -- | Mar 15, 2024 |
| FURLONG TAMMY CPA Chief Financial Officer | -- | Direct | -- | Feb 15, 2024 |
| FERRA JOSEPH J. JR. Chief Executive Officer | -- | Direct | -- | Dec 15, 2023 |
| FERRA JOSEPH J. JR. Chief Executive Officer | -- | Direct | -- | Sep 15, 2023 |
| CLACKSON TIMOTHY P Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 1, 2023 |
| FERRA JOSEPH J. JR. Chief Executive Officer | -- | Direct | -- | Jun 16, 2023 |
| FERRA JOSEPH J. JR. Chief Executive Officer | -- | Direct | -- | Mar 16, 2023 |
| FERRA JOSEPH J. JR. Chief Financial Officer | -- | Direct | -- | Dec 16, 2022 |
| CLACKSON TIMOTHY P Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 31, 2022 |
| VENBIO GLOBAL STRATEGIC FUND III, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.12 per share. | Indirect | 2,897,806 | May 25, 2022 |
| CORMORANT ASSET MANAGEMENT ,L.P Former | Purchase at price 12.74 per share. | Indirect | 3,185,000 | Jun 29, 2021 |
| CORMORANT ASSET MANAGEMENT ,L.P Former | -- | Indirect | -- | Jun 29, 2021 |
| AISLING CAPITAL IV, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.74 per share. | Indirect | 2,388,750 | Jun 29, 2021 |
| AISLING CAPITAL IV, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 29, 2021 |
| VERTEX GLOBAL HC FUND II PTE. LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.69 per share. | Direct | 2,922,500 | Jun 29, 2021 |
| VERTEX GLOBAL HC FUND II PTE. LTD. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Jun 29, 2021 |
| VENBIO GLOBAL STRATEGIC FUND III, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.74 per share. | Indirect | 7,962,500 | Jun 29, 2021 |
| VENBIO GLOBAL STRATEGIC FUND III, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 29, 2021 |
| QIMING U.S. HEALTHCARE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.74 per share. | Indirect | 3,981,250 | Jun 29, 2021 |
| QIMING U.S. HEALTHCARE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Jun 29, 2021 |
Related Tickers
CLSD Clearside Biomedical, Inc.
1.3400
+6.35%
VINC Vincerx Pharma, Inc.
0.7300
-18.59%
INAB IN8bio, Inc.
1.0400
0.00%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
LPTX Leap Therapeutics, Inc.
3.2500
+2.52%
BCAB BioAtla, Inc.
2.5400
+12.89%
ACRV Acrivon Therapeutics, Inc.
8.46
-0.12%
IKNA Ikena Oncology, Inc.
1.3000
-0.76%
RZLT Rezolute, Inc.
2.6600
+2.31%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%